Steward Partners Investment Advisory, LLC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 226 filers reported holding EDITAS MEDICINE INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$5,008
-27.3%
642
-23.3%
0.00%
Q2 2023$6,889
-34.3%
837
-42.2%
0.00%
Q1 2023$10,491
+25.2%
1,447
+53.1%
0.00%
Q4 2022$8,382
-23.8%
945
+9.2%
0.00%
Q3 2022$11,000
+22.2%
865
+9.5%
0.00%
Q2 2022$9,000
-64.0%
790
-38.8%
0.00%
Q1 2022$25,000
-37.5%
1,291
-14.4%
0.00%
-100.0%
Q4 2021$40,000
-76.7%
1,508
-64.1%
0.00%
-66.7%
Q3 2021$172,000
+39.8%
4,198
+92.7%
0.00%
+50.0%
Q2 2021$123,000
-99.9%
2,179
-58.6%
0.00%0.0%
Q1 2021$220,836,000
+441572.0%
5,258
+638.5%
0.00%
+100.0%
Q4 2020$50,000
+1150.0%
712
+439.4%
0.00%
Q3 2020$4,000
+300.0%
132
+180.9%
0.00%
Q2 2020$1,000
-95.7%
47
-94.1%
0.00%
-100.0%
Q4 2019$23,000
-36.1%
800
-50.0%
0.00%0.0%
Q3 2019$36,000
+33.3%
1,600
+45.5%
0.00%0.0%
Q2 2019$27,000
-27.0%
1,100
-4.3%
0.00%
-50.0%
Q3 2018$37,000
+48.0%
1,150
+64.3%
0.00%
+100.0%
Q2 2018$25,000
+38.9%
700
+27.3%
0.00%0.0%
Q1 2018$18,000
+5.9%
550
-4.3%
0.00%0.0%
Q4 2017$17,000
+325.0%
575
+187.5%
0.00%
Q3 2017$4,000
+33.3%
2000.0%0.00%
Q2 2017$3,000
-25.0%
2000.0%0.00%
-100.0%
Q1 2017$4,000
+33.3%
2000.0%0.00%0.0%
Q4 2016$3,0002000.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q1 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders